The multiple roles of estrogens and the enzyme aromatase

Progress in Brain Research

Volumn 181, Issue C, 2010, Pages 209-232

  Boon, Wah Chin ^a,b,c,d   Chow, Jenny D Y ^c,d   Simpson, Evan R ^c,d  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Aromatase; Brain; Cyp19; Estrogens; Neuroprotection

Indexed keywords

17 HYDROXYPREGNENOLONE; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANDROSTENEDIONE; AROMATASE; CHOLESTEROL; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYTOCHROME P450; CYTOCHROME P450 17; ESTRADIOL; ESTRIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYPROGESTERONE; INSULIN; LEPTIN; NEUROTRANSMITTER; NEUROTRANSMITTER RECEPTOR; PRASTERONE; PREGNENOLONE; PROGESTERONE; STEROID 16ALPHA MONOOXYGENASE; STEROID 17ALPHA MONOOXYGENASE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE; TRIACYLGLYCEROL; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; NEUROPROTECTIVE AGENT;

ADIPOSE TISSUE; ADRENAL GLAND; AGGRESSION; ALLOSTERISM; ANOVULATION; APOPTOSIS; AROMATIZATION; ARTICLE; BEHAVIOR; BONE; BONE DENSITY; BRAIN; BRAIN METABOLISM; BREAST CANCER; CARDIOVASCULAR SYSTEM; CATALYSIS; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CHOLESTEROL LIVER LEVEL; DENDRITIC SPINE; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME REGULATION; ESTROGEN DEFICIENCY; ESTROGEN SYNTHESIS; FATTY LIVER; FEMALE INFERTILITY; FETUS (ANATOMY); GENE DELETION; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE MUTATION; GLUCOSE METABOLISM; GRANULOSA CELL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIVER; MALE INFERTILITY; METABOLIC DISORDER; METABOLISM; NERVE CELL; NEUROPROTECTION; NONHUMAN; OBESITY; OBSESSIVE COMPULSIVE DISORDER; OSSIFICATION; OSTEOLYSIS; OVARIAN BLEEDING; OVARY; OVARY FOLLICLE DEVELOPMENT; PLACENTA; PRIORITY JOURNAL; PROSTATE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPRODUCTION; SEXUAL BEHAVIOR; SKIN; SPATIAL MEMORY; STEROIDOGENESIS; TESTIS; UTERUS; VASCULAR ENDOTHELIUM; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; GENE SILENCING; GENETICS; HISTOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

ANIMALS; AROMATASE; BRAIN; ESTROGENS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE KNOCKDOWN TECHNIQUES; GLUCOSE; HUMANS; MOLECULAR STRUCTURE; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTRANSMITTER AGENTS; REPRODUCTION; SEXUAL BEHAVIOR, ANIMAL; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 77955479427     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)81012-6     Document Type: Article

References (204)

1. Abdelgadir, S. E., Resko, J. A., Ojeda, S. R., Lephart, E. D., McPhaul, M. J., & Roselli, C. E. (1994). Androgens regulate aromatase cytochrome P450 messenger ribonucleic acid in rat brain. Endocrinology, 135, 395-401.
2. Abe-Dohmae, S., Takagi, Y., & Harada, N. (1996). Neurotransmitter-mediated regulation of brain aromatase: Protein kinase C-and G-dependent induction. Journal of Neurochemistry, 67, 2087-2095.
3. Adams, M. M., Oung, T., Morrison, J. H., & Gore, A. C. (2001). Length of postovariectomy interval and age, but not estrogen replacement, regulate N-methyl-D-aspartate receptor mRNA levels in the hippocampus of female rats. Experimental Neurology, 170, 345-356.
4. Akama, K. T. & McEwen, B. S. (2003). Estrogen stimulates postsynaptic density-95 rapid protein synthesis via the akt/ protein kinase B pathway. Journal of Neuroscience, 23, 2333-2339.
5. Allen, E. & Doisy, E. A. (1983). Landmark article Sept 8, 1923. An ovarian hormone. Preliminary report on its localization, extraction and partial purification, and action in test animals. By Edgar Allen and Edward A. Doisy. JAMA, 250, 2681-2683.
6. Azcoitia, I., Sierra, A., & Garcia-Segura, L. M. (1999). Localization of estrogen receptor beta-immunoreactivity in astrocytes of the adult rat brain. Glia, 26, 260-267.
7. Azcoitia, I., Sierra, A., Veiga, S., Honda, S., Harada, N., & Garcia-Segura, L. M. (2001). Brain aromatase is neuroprotective. Journal of Neurobiology, 47, 318-329.
8. Bakker, J., Honda, S. I., Harada, N., & Balthazart, J. (2002). The aromatase knock-out mouse provides new evidence that estradiol is required during development in the female for the expression of sociosexual behaviors in adulthood. Journal of Neuroscience, 22, 9104-9112.
9. Bakker, J., Honda, S., Harada, N., & Balthazart, J. (2004). Restoration of male sexual behavior by adult exogenous estrogens in male aromatase knockout mice. Hormones and Behavior, 46, 1-10.
10. Balthazart, J., Baillien, M., & Ball, G. F. (2001a). Phosphorylation processes mediate rapid changes of brain aromatase activity. The Journal of Steroid Biochemistry and Molecular Biology, 79, 261-277.
11. Balthazart, J., Baillien, M., & Ball, G. F. (2001b). Phosphorylation processes mediate rapid changes of brain aromatase activity. The Journal of Steroid Biochemistry and Molecular Biology, 79, 261-277.
12. Balthazart, J., Baillien, M., & Ball, G. F. (2001c). Rapid and reversible inhibition of brain aromatase activity. Journal of Neuroendocrinology, 13, 63-73.
13. Balthazart, J. & Ball, G. F. (2006). Is brain estradiol a hormone or a neurotransmitter? Trends in Neurosciences, 29, 241-249.
14. Baquedano, M. S., Saraco, N., et al. (2007). Identification and developmental changes of aromatase and estrogen receptor expression in prepubertal and pubertal human adrenal tissues. Journal of Clinical Endocrinology and Metabolism, 92 (6), 2215-2222.
15. Bhavnani, B. R. (2003). Estrogens and menopause: Pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's. The Journal of Steroid Biochemistry and Molecular Biology, 85, 473-482.
16. Boon, W. C., Diepstraten, J., van der Burg, J., Jones, M. E., Simpson, E. R., & van den Buuse, M. (2005). Hippocampal NMDA receptor subunit expression and watermaze learning in estrogen deficient female mice. Brain Research. Molecular Brain Research, 140, 127-132.
17. Brewer, G. J., Reichensperger, J. D., & Brinton, R. D. (2006). Prevention of age-related dysregulation of calcium dynamics by estrogen in neurons. Neurobiology of Aging, 27, 306-317.
18. Britt, K.L., Drummond, A.E., et al. (2001). The ovarian phenotype of the aromatase knockout (ArKO) mouse. The Journal of Steroid Biochemistry and Molecular Biology, 79 (1-5), 181-185.
19. Britt, K. L., Saunders, P. K., McPherson, S. J., Misso, M. L., Simpson, E. R., & Findlay, J. K. (2004). Estrogen actions on follicle formation and early follicle development. Biology of Reproduction, 71, 1712-1723.
20. Brodie, A. & Inkster, S. (1993). Aromatase in the human testis. The Journal of Steroid Biochemistry and Molecular Biology, 44, 549-555.
21. Bukovsky, A., Caudle, M.R., et al. (2003). Placental expression of estrogen receptor beta and its hormone binding variant -comparison with estrogen receptor alpha and a role for estrogen receptors in asymmetric division and differentiation of estrogen-dependent cells. Reproductive Biology and Endocrinology, 1, 36.
22. Bulun, S.E., Imir, G., et al. (2005). Aromatase in endometriosis and uterine leiomyomata. The Journal of Steroid Biochemistry and Molecular Biology, 95(1-5), 57-62.
23. Bulun, S. E., Sebastian, S., Takayama, K., Suzuki, T., Sasano, H., & Shozu, M. (2003). The human CYP19 (aromatase P450) gene: Update on physiologic roles and genomic organization of promoters. The Journal of Steroid Biochemistry and Molecular Biology, 86, 219-224.
24. Canonico, M., Plu-Bureau, L. G.D., & Scarabin, P. Y. (2008). Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: Systematic review and meta-analysis. BMJ, 336, 1227-1231.
25. Carani, C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., et al. (1997). Effect of testosterone and estradiol in a man with aromatase deficiency. The New England Journal of Medicine, 337, 91-95.
26. Carani, C., Rochira, V., Faustini-Fustini, M., Balestrieri, A., & Granata, A. R. (1999). Role of oestrogen in male sexual behaviour: Insights from the natural model of aromatase deficiency. Clinical Endocrinology (Oxford), 51, 517-524.
27. Carpino, A., Romeo, F., & Rago, V. (2004). Aromatase immunolocalization in human ductuli efferentes and proximal ductus epididymis. Journal of Anatomy, 204, 217-220.
28. Carrer, H. F., Cambiasso, M. J., Brito, V., & Gorosito, S. (2003). Neurotrophic factors and estradiol interact to control axogenic growth in hypothalamic neurons. Annals of the New York Academy of Sciences, 1007, 306-316.
29. Catalano, S., Barone, I., Giordano, C., Rizza, P., Qi, H., Gu, G., et al. (2009). Rapid estradiol/ERalpha signaling enhances aromatase enzymatic activity in breast cancer cells. Molecular Endocrinology, 23, 1634-1645.
30. Cheng, C. M., Cohen, M., Wang, J., & Bondy, C. A. (2001). Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex. The FASEB Journal, 15, 907-915.
31. Chow, J. D., Simpson, E. R., & Boon, W. C. (2009). Alternative 50-untranslated first exons of the mouse Cyp19A1 (aromatase) gene. The Journal of Steroid Biochemistry and Molecular Biology, 115, 115-125.
32. Conley, A. & Hinshelwood, M. (2001). Mammalian aromatases. Reproduction, 121, 685-695.
33. Corbin, C. J., Berger, T., Ford, J. J., Roselli, C. E., Sienkiewicz, W., Trainor, B. C., et al. (2009). Porcine hypothalamic aromatase cytochrome P450: Isoform characterization, sexdependent activity, regional expression, and regulation by enzyme inhibition in neonatal boars. Biology of Reproduction, 81, 388-395.
34. Cruz, M.N., Agewall, S., et al. (2008). Acute dilatation to phytoestrogens and estrogen receptor subtypes expression in small arteries from women with coronary heart disease. Atherosclerosis, 196(1), 49-58.
35. Dalla, C., Antoniou, K., Papadopoulou-Daifoti, Z., Balthazart, J., & Bakker, J. (2004). Oestrogen-deficient female aromatase knockout (ArKO) mice exhibit depressive-like symptomatology. European Journal of Neuroscience, 20, 217-228.
36. Dalla, C., Antoniou, K., et al. (2005). Male aromatase-knockout mice exhibit normal levels of activity, anxiety and depressive-like symptomatology. Behavioural Brain Research, 163(2), 186-193.
37. d'Anglemont de Tassigny, X., Campagne, C., Steculorum, S., & Prevot, V. (2009). Estradiol induces physical association of neuronal nitric oxide synthase with NMDA receptor and promotes nitric oxide formation via estrogen receptor activation in primary neuronal cultures. Journal of Neurochemistry, 109, 214-224.
38. de Castilhos, J., Forti, C. D., Achaval, M., & Rasia-Filho, A. A. (2008). Dendritic spine density of posterodorsal medial amygdala neurons can be affected by gonadectomy and sex steroid manipulations in adult rats: A Golgi study. Brain Research, 1240, 73-81.
39. Demura, M., Reierstad, S., Innes, J. E., & Bulun, S. E. (2008). Novel promoter I.8 and promoter usage in the CYP19 (aromatase) gene. Reproduction Science, 15, 1044-1053.
40. Dominguez, R., Liu, R., & Baudry, M. (2007). 17-Beta-estradiol-mediated activation of extracellular-signal regulated kinase, phosphatidylinositol 3-kinase/protein kinase B-Akt and N-methyl-D-aspartate receptor phosphorylation in cortical synaptoneurosomes. Journal of Neurochemistry, 101, 232-240.
41. Ellem, S.J., Schmitt, J.F., et al. (2004). Local aromatase expression in human prostate is altered in malignancy. Journal of Clinical Endocrinology and Metabolism, 89(5), 2434-2441.
42. Emilien, G., Beyreuther, K., Masters, C. L., & Maloteaux, J. M. (2000). Prospects for pharmacological intervention in Alzheimer disease. Archives of Neurology, 57, 454-459.
43. Fisher, C. R., Graves, K. H., Parlow, A. F., & Simpson, E. R. (1998). Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proceedings of the National Academy of Sciences of the United States of America, 95, 6965-6970.
44. Frankfurt, M., Gould, E., Woolley, C. S., & McEwen, B. S. (1990). Gonadal steroids modify dendritic spine density in ventromedial hypothalamic neurons: A Golgi study in the adult rat. Neuroendocrinology, 51, 530-535.
45. Fried, G., Andersson, E., et al. (2004). Estrogen receptor beta is expressed in human embryonic brain cells and is regulated by 17beta-estradiol. European Journal of Neuroscience, 20(9), 2345-2354.
46. Galmiche, G., Corvaisier, S., & Kottler,M. L. (2006). Aromatase gene expression and regulation in the female rat pituitary. Annals of the New York Academy of Sciences, 1070, 286-292.
47. Garcia-Segura, L. M., Wozniak, A., Azcoitia, I., Rodriguez, J. R., Hutchison, R. E., & Hutchison, J. B. (1999). Aromatase expression by astrocytes after brain injury: Implications for local estrogen formation in brain repair. Neuroscience, 89, 567-578.
48. Ghosh, D., Griswold, J., Erman, M., & Pangborn, W. (2009). Structural basis for androgen specificity and oestrogen synthesis in human aromatase. Nature, 457, 219-223.
49. Glatstein, I.Z. & Yeh, J. (1995). Ontogeny of the estrogen receptor in the human fetal uterus. Journal of Clinical Endocrinology and Metabolism, 80(3), 958-964.
50. Golovine, K., Schwerin, M., & Vanselow, J. (2003). Three different promoters control expression of the aromatase cytochrome p450 gene (cyp19) in mouse gonads and brain. Biology of Reproduction, 68, 978-984.
51. Gonzalez, M., Cabrera-Socorro, A., Perez-Garcia, C. G., Fraser, J.D., Lopez, F. J.,Alonso,R., et al. (2007).Distribution patterns of estrogen receptor alpha and beta in the human cortex and hippocampus during development and adulthood. The Journal of Comparative Neurology, 503, 790-802.
52. Grandien, K. (1996). Determination of transcription start sites in the human estrogen receptor gene and identification of a novel, tissue-specific, estrogen receptor-mRNA isoform. Molecular and Cellular Endocrinology, 116(2), 207-212.
53. Grandien, K. (1996). Determination of transcription start sites in the human estrogen receptor gene and identification of a novel, tissue-specific, estrogen receptor-mRNA isoform. Mol Cell Endocrinol, 116(2): 207-212.
54. Green, P. S., Bales, K., Paul, S., & Bu, G. (2005). Estrogen therapy fails to alter amyloid deposition in the PDAPP model of Alzheimer's disease. Endocrinology, 146, 2774-2781.
55. Harada, N. (1992). A unique aromatase (P-450AROM) mRNA formed by alternative use of tissue-specific exons 1 in human skin fibroblasts. Biochemical and Biophysical Research Communications, 189, 1001-1007.
56. Harada, N., Ogawa, H., Shozu, M., & Yamada, K. (1992). Genetic studies to characterize the origin of the mutation in placental aromatase deficiency. The American Journal of Human Genetics, 51, 666-672.
57. Harada, N., Wakatsuki, T., Aste, N., Yoshimura, N., & Honda, S. I. (2009). Functional analysis of neurosteroidal oestrogen using gene-disrupted and transgenic mice. Journal of Neuroendocrinology, 21, 365-369.
58. Haczynski, J., Tarkowski, R., et al. (2002). Human cultured skin fibroblasts express estrogen receptor alpha and beta. International Journal of Molecular Medicine, 10(2), 149-153.
59. Head, G. A., Obeyesekere, V. R., Jones, M. E., Simpson, E. R., & Krozowski, Z. S. (2004). Aromatase-deficient (ArKO) mice have reduced blood pressure and baroreflex sensitivity. Endocrinology, 145, 4286-4291.
60. Hess,R.A. (2003). Estrogen in the adult male reproductive tract: A review. Reproductive Biology and Endocrinology, 1, 52.
61. Hewitt, K. N., Pratis, K., Jones, M. E., & Simpson, E. R. (2004). Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology, 145, 1842-1848.
62. Hewitt, K. N., Boon, W. C. et al. (2003). The aromatase knockout mouse presents with a sexually dimorphic disruption to cholesterol homeostasis. Endocrinology, 144 (9), 3895-3903.
63. Hill, R. A. & Boon, W. C. (2009). Estrogens, brain, and behavior: Lessons from knockout mouse models. Seminars in Reproductive Medicine, 27, 218-228.
64. Hill, R. A., Chow, J., Fritzemeier, K., Simpson, E. R., & Boon, W. C. (2007a). Fas/FasL-mediated apoptosis in the arcuate nucleus and medial preoptic area of male ArKO mice is ameliorated by selective estrogen receptor alpha and estrogen receptor beta agonist treatment, respectively. Molecular and Cellular Neuroscience, 36, 146-157.
65. Hill, R. A., Chua, H. K. et al. (2009). Estrogen deficiency results in apoptosis in the frontal cortex of adult female aromatase knockout mice. Mol Cellular Neurosci, 41(1), 1-7.
66. Hill, R. A., McInnes, K. J., Gong, E. C., Jones, M. E., Simpson, E. R., & Boon, W. C. (2007b). Estrogen deficient male mice develop compulsive behavior. Biological Psychiatry, 61, 359-366.
67. Hill, R. A., Pompolo, S., Jones, M. E.E., Simpson, E. R., & Boon, W. C. (2004). Estrogen deficiency leads to apoptosis in dopaminergic neurons in the medial pre-optic area and arcuate nucleus of male mice. Molecular and Cellular Neuroscience, 27, 466-476.
68. Hill, R. A., Pompolo, S., Jones, M. E., Simpson, E. R., & Boon, W. C. (2004). Estrogen deficiency leads to apoptosis in dopaminergic neurons in the medial preoptic area and arcuate nucleus of male mice. Molecular and Cellular Neuroscience, 27, 466-476.
69. Hodges, Y.K., Tung, L., et al. (2000). Estrogen receptors alpha and beta: prevalence of estrogen receptor beta mRNA in human vascular smooth muscle and transcriptional effects. Circulation, 101(15), 1792-1798.
70. Hojo, Y., Hattori, T. A., Enami, T., Furukawa, A., Suzuki, K., Ishii, H. T., et al. (2004). Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017alpha and P450 aromatase localized in neurons. Proceedings of the National Academy of Sciences of the United States of America, 101, 865-870.
71. Honda, S., Harada, N., Ito, S., Takagi, Y., & Maeda, S. (1998). Disruption of sexual behavior in male aromatasedeficient mice lacking exons 1 and 2 of the cyp19 gene. Biochemical and Biophysical Research Communications, 252, 445-449.
72. Honda, S., Harada, N., & Takagi, Y. (1994). Novel exon 1 of the aromatase gene specific for aromatase transcripts in human brain. Biochemical and Biophysical Research Communications, 198, 1153-1160.
73. Honda, S., Harada, N., & Takagi, Y. (1996). The alternative exons 1 of the mouse aromatase cytochrome P-450 gene. Biochimica et Biophysica Acta, 1305, 145-150.
74. Horvath, T. L., Roa-Pena, L., Jakab, R. L., Simpson, E. R., & Naftolin, F. (1997). Aromatase in axonal processes of early postnatal hypothalamic and limbic areas including the cingulate cortex. The Journal of Steroid Biochemistry and Molecular Biology, 61, 349-357.
75. Hoyland, J.A., Mee, A.P., et al. (1997). Demonstration of estrogen receptor mRNA in bone using in situ reverse-transcriptase polymerase chain reaction. Bone, 20(2), 87-92.
76. Huang, R. & Poduslo, S. E. (2006). CYP19 haplotypes increase risk for Alzheimer's disease. Journal of Medical Genetics, 43, e42.
77. Hutchison, J. B., Beyer, C., Hutchison, R. E., & Wozniak, A. (1997). Sex differences in the regulation of embryonic brain aromatase. The Journal of Steroid Biochemistry and Molecular Biology, 61, 315-322.
78. Huynh, K., Jones, G., Thouas, G., Britt, K. L., Simpson, E. R., & Jones, M. E. (2004). Estrogen is not directly required for oocyte developmental competence. Biology of Reproduction, 70, 1263-1269.
79. Iivonen, S., Corder, E., Lehtovirta, M., Helisalmi, S., Mannermaa, A., Vepsalainen, S., et al. (2004). Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease. Neurology, 62, 1170-1176.
80. Ishunina, T. A. & Swaab, D. F. (2003). Increased neuronal metabolic activity and estrogen receptors in the vertical limb of the diagonal band of Broca in Alzheimer's disease: Relation to sex and aging. Experimental Neurology, 183, 159-172.
81. Ishunina, T. A., van Beurden, D., van der, M. G., Unmehopa, U. A., Hol, E. M., Huitinga, I., et al. (2005). Diminished aromatase immunoreactivity in the hypothalamus, but not in the basal forebrain nuclei in Alzheimer's disease. Neurobiology of Aging, 26, 173-194.
82. Jelks, K. B., Wylie, R., Floyd, C. L., McAllister, A. K., & Wise, P. (2007). Estradiol targets synaptic proteins to induce glutamatergic synapse formation in cultured hippocampal neurons: Critical role of estrogen receptor-alpha. Journal of Neuroscience, 27, 6903-6913.
83. Jones, M. E., Boon, W. C., McInnes, K., Maffei, L., Carani, C., & Simpson, E. R. (2007). Recognizing rare disorders: Aromatase deficiency. Nature Clinical Practice Endocrinology and Metabolism, 3, 414-421.
84. Jones, M. E., Thorburn, A. W., Britt, K. L., Hewitt, K. N., Wreford, N. G., Proietto, J., et al. (2000). Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proceedings of the National Academy of Sciences of the United States of America, 97, 12735-12740.
85. Kadioglu, P., Oral, G., Sayitoglu, M., Erensoy, N., Senel, B., Gazioglu, N., et al. (2008). Aromatase cytochrome P450 enzyme expression in human pituitary. Pituitary, 11, 29-35.
86. Kazeto, Y., Ijiri, S., Place, A. R., Zohar, Y., & Trant, J. M. (2001). The 50-flanking regions of CYP19A1 and CYP19A2 in zebrafish. Biochemical and Biophysical Research Communications, 288, 503-508.
87. Kilgore, M. W., Means, G. D., Mendelson, C. R., & Simpson, E. R. (1992). Alternative promotion of aromatase P-450 expression in the human placenta. Molecular and Cellular Endocrinology, 83, R9-R16.
88. Kimura, M., Sudhir, K., et al. (2003). Impaired acetylcholineinduced release of nitric oxide in the aorta of male aromatase-knockout mice: regulation of nitric oxide production by endogenous sex hormones in males. Circulation Research, 93(12), 1267-1271.
89. Knopp, R. H., Paramsothy, P., Retzlaff, B. M., Fish, B., Walden, C., Dowdy, A., et al. (2006). Sex differences in lipoprotein metabolism and dietary response: Basis in hormonal differences and implications for cardiovascular disease. Current Cardiology Reports, 8, 452-459.
90. Kostanyan, A. & Nazaryan, K. (1992). Rat brain glycolysis regulation by estradiol-17 beta. Biochimica et Biophysica Acta, 1133, 301-306.
91. Kumar, P., Kamat, A., & Mendelson, C. R. (2009). Estrogen receptor alpha (ERalpha) mediates stimulatory effects of estrogen on aromatase (CYP19) gene expression in human placenta. Molecular Endocrinology, 23, 784-793.
92. Lambard, S., Galeraud-Denis, I., Saunders, P. T., & Carreau, S. (2004). Human immature germ cells and ejaculated spermatozoa contain aromatase and oestrogen receptors. Journal of Molecular Endocrinology, 32, 279-289.
93. Lanfranco, F., Zirilli, L., Baldi, M., Pignatti, E., Corneli, G., Ghigo, E., et al. (2008). A novel mutation in the human aromatase gene: Insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment. Bone, 43, 628-635.
94. Larionov, A. A., Vasyliev, D. A., Mason, J. I., Howie, A. F., Berstein, L. M., & Miller, W. R. (2003). Aromatase in skeletal muscle. The Journal of Steroid Biochemistry and Molecular Biology, 84, 485-492.
95. Leav, I., Lau, K.M., et al. (2001). Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. The American Journal of Pathology, 159(1), 79-92.
96. Lecce, G., Meduri, G., et al. (2001). Presence of estrogen receptor beta in the human endometrium through the cycle: expression in glandular, stromal, and vascular cells. Journal of Clinical Endocrinology and Metabolism, 86(3), 1379-1386.
97. Lephart, E. D. (1996). A review of brain aromatase cytochrome P450. Brain Research. Brain Research Reviews, 22, 1-26.
98. Lephart, E. D., Call, S. B., Rhees, R. W., Jacobson, N. A., Weber, K. S., Bledsoe, J., et al. (2001a). Neuroendocrine regulation of sexually dimorphic brain structure and associated sexual behavior in male rats is genetically controlled. Biology of Reproduction, 64, 571-578.
99. Lephart, E. D., Lund, T. D., & Horvath, T. L. (2001b). Brain androgen and progesterone metabolizing enzymes: Biosynthesis, distribution and function. Brain Research. Brain Research Reviews, 37, 25-37.
100. Levin-Allerhand, J., McEwen, B. S., Lominska, C. E., Lubahn, D.B.,Korach, K. S.,&Smith, J. D. (2001).Brain region-specific up-regulation of mouse apolipoprotein E by pharmacological estrogen treatments. Journal of Neurochemistry, 79, 796-803.
101. Li, C. L., Toda, K., et al. (2002). Estrogen deficiency results in enhanced expression of smoothened of the hedgehog signaling in the thymus and affects thymocyte development. International Immunopharmacology, 2(6), 823-833.
102. Ling, S., Dai, A., et al. (2004). Endogenous estrogen deficiency reduces proliferation and enhances apoptosis-related death in vascular smooth muscle cells: insights from the aromataseknockout mouse. Circulation, 109(4), 537-543.
103. MacGillivray, M. H., Morishima, A., Conte, F., Grumbach, M., & Smith, E. P. (1998). Pediatric endocrinology update: An overview. The essential roles of estrogens in pubertal growth, epiphyseal fusion and bone turnover: Lessons from mutations in the genes for aromatase and the estrogen receptor. Hormone Research, 49(Suppl. 1), 2-8.
104. Mahendroo, M.S., Means, G.D., et al. (1991). Tissue-specific expression of human P-450AROM. The promoter responsible for expression in adipose tissue is different from that utilized in placenta. The Journal of Biological Chemistry, 266(17), 11276-11281.
105. Mahendroo, M. S., Mendelson, C. R., & Simpson, E. R. (1993). Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. The Journal of Biological Chemistry, 268, 19463-19470.
106. Mahmoodzadeh, S., Fritschka, S., et al. (2009). Nuclear factorkappaB regulates estrogen receptor-alpha transcription in the human heart. The Journal of Biological Chemistry, 284(37), 24705-24714.
107. Makinen, S., Makela, S., et al. (2001). Localization of oestrogen receptors alpha and beta in human testis. Molecular Reproduction and Development, 7(6), 497-503.
108. Mannella, P. & Brinton, R. D. (2006). Estrogen receptor protein interaction with phosphatidylinositol 3-kinase leads to activation of phosphorylated Akt and extracellular signalregulated kinase 1/2 in the same population of cortical neurons: A unified mechanism of estrogen action. Journal of Neuroscience, 26, 9439-9447.
109. Martin, S., Jones, M., Simpson, E., & van den Buuse, M. (2003). Impaired spatial reference memory in aromatasedeficient (ArKO) mice. NeuroReport, 14, 1979-1982.
110. McCullough, L. D., Blizzard, K., Simpson, E. R., Oz, O. K., & Hurn, P. D. (2003). Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection. Journal of Neuroscience, 23, 8701-8705.
111. McEwen, B., Akama, K., Alves, S., Brake, W. G., Bulloch, K., Lee, S., et al. (2001). Tracking the estrogen receptor in neurons: Implications for estrogen-induced synapse formation. Proceedings of the National Academy of Sciences of the United States of America, 98, 7093-7100.
112. McNatty, K. P., Baird, D. T., Bolton, A., Chambers, P., Corker, C. S., & McLean, H. (1976). Concentration of oestrogens and androgens in human ovarian venous plasma and follicular fluid throughout the menstrual cycle. Journal of Endocrinology, 71, 77-85.
113. McPherson, S. J., Wang, H., Jones, M. E., Pedersen, J., Iismaa, T. P., Wreford, N., et al. (2001). Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland. Endocrinology, 142, 2458-2467.
114. Means, G. D., Mahendroo, M. S., Corbin, C. J., Mathis, J. M., Powell, F. E., Mendelson, C. R., et al. (1989). Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. The Journal of Biological Chemistry, 264, 19385-19391.
115. Means, G.D., Kilgore, M.W., et al. (1991). Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues. Molecular Endocrinology, 5(12), 2005-2013.
116. Mendelsohn, M. E. (2009). Estrogen actions in the cardiovascular system. Climacteric, 12(Suppl. 1), 18-21.
117. Miyaura, C., Toda, K., et al. (2001). Sex-and age-related response to aromatase deficiency in bone. Biochemical and Biophysical Research Communications, 280(4), 1062-1068.
118. Michael, M. D., Kilgore, M. W., Morohashi, K., & Simpson, E. R. (1995). Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary. The Journal of Biological Chemistry, 270, 13561-13566.
119. Miller, T. W., Shin, I., Kagawa, N., Evans, D. B., Waterman, M. R., & Arteaga, C. L. (2008). Aromatase is phosphorylated in situ at serine-118. The Journal of Steroid Biochemistry and Molecular Biology, 112, 95-101.
120. Misso, M. L., Murata, Y., Boon, W. C., Jones, M. E., Britt, K. L., & Simpson, E. R. (2003). Cellular and molecular characterization of the adipose phenotype of the aromatasedeficient mouse. Endocrinology, 144, 1474-1480.
121. Mitra, S. W., Hoskin, E., Yudkovitz, J., Pear, L., Wilkinson, H. A., Hayashi, S., et al. (2003). Immunolocalization of estrogen receptor beta in the mouse brain: Comparison with estrogen receptor alpha. Endocrinology, 144, 2055-2067.
122. Moore, J.T., McKee, D.D., et al. (1998). Cloning and characterization of human estrogen receptor beta isoforms. Biochemical and Biophysical Research Communications, 247(1), 75-78.
123. Morale, M. C., L'episcopo, F., Tirolo, C., Giaquinta, G., Caniglia, S., Testa, N., et al. (2008). Loss of aromatase cytochrome P450 function as a risk factor for Parkinson's disease? Brain Research Reviews, 57, 431-443.
124. Morale, M. C., Serra, P. A., L'episcopo, F., Tirolo, C., Caniglia, S., Testa, N., et al. (2006). Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: Glia dictates resistance versus vulnerability to neurodegeneration. Neuroscience, 138, 869-878.
125. Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., & Qin, K. (1995). Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. Journal of Clinical Endocrinology and Metabolism, 80, 3689-3698.
126. Miyaura, C., K. Toda, et al. (2001). Sex-and age-related response to aromatase deficiency in bone. Biochem Biophys Res Commun, 280(4): 1062-1068.
127. Mulnard, R. A., Cotman, C. W., Kawas, C., van Dyck, C. H., Sano, M., Doody, R., et al. (2000). Estrogen replacement therapy for treatment of mild to moderate alzheimer disease: a randomized controlled trial. Alzheimer's disease cooperative study. JAMA, 283(8), 1007-1015.
128. Mylonas, I., Jeschke, U., et al. (2004). Immunohistochemical analysis of estrogen receptor alpha, estrogen receptor beta and progesterone receptor in normal human endometrium. Acta Histochemica, 106(3), 245-252.
129. Naftolin, F., Horvath, T. L., & Balthazart, J. (2001). Estrogen synthetase (aromatase) immunohistochemistry reveals concordance between avian and rodent limbic systems and hypothalami. Experimental Biology and Medicine (Maywood), 226, 717-725.
130. Naftolin, F., Horvath, T. L., Jakab, R. L., Leranth, C., Harada, N., & Balthazart, J. (1996). Aromatase immunoreactivity in axon terminals of the vertebrate brain. An immunocytochemical study on quail, rat, monkey and human tissues. Neuroendocrinology, 63, 149-155.
131. Naftolin, F. & MacLusky, N. J. (1982). Aromatase in the central nervous system. Cancer Research, 42, 3274s-3276s.
132. Naftolin, F., Ryan, K. J., Davies, I. J., Reddy, V. V., Flores, F., Petro, Z., et al. (1975). The formation of estrogens by central neuroendocrine tissues. Recent Progress in Hormone Research, 31, 295-319.
133. Nawata, H., Tanaka, S., Tanaka, S., Takayanagi, R., Sakai, Y., Yanase, T., et al. (1995). Aromatase in bone cell: Association with osteoporosis in postmenopausal women. The Journal of Steroid Biochemistry and Molecular Biology, 53, 165-174.
134. Nemoto, Y., Toda, K., Ono, M., Fujikawa-Adachi, K., Saibara, T., Onishi, S., et al. (2000). Altered expression of fatty acidmetabolizing enzymes in aromatase-deficient mice. The Journal of Clinical Investigation, 105, 1819-1825.
135. Nilsen, J., Irwin, R. W., Gallaher, T. K., & Brinton, R. D. (2007). Estradiol in vivo regulation of brain mitochondrial proteome. Journal of Neuroscience, 27, 14069-14077.
136. Osawa, Y., Higashiyama, T., Fronckowiak, M., Yoshida, N., & Yarborough, C. (1987). Aromatase. The Journal of Steroid Biochemistry, 27, 781-789.
137. Osterlund, M.K., Grandien, K., et al. (2000). The human brain has distinct regional expression patterns of estrogen receptor alpha mRNA isoforms derived from alternative promoters. Journal of Neurochemistry, 75(4), 1390-1397.
138. Oz, O. K., Hirasawa, G., Lawson, J., Nanu, L., Constantinescu, A., Antich, P. P., et al. (2001). Bone phenotype of the aromatase deficient mouse. The Journal of Steroid Biochemistry and Molecular Biology, 79, 49-59.
139. Pasqualini, C., Olivier, V., Guibert, B., Frain, O., & Leviel, V. (1995). Acute stimulatory effect of estradiol on striatal dopamine synthesis. Journal of Neurochemistry, 65, 1651-1657.
140. Pasquali, D., Staibano, S., et al. (2001). Estrogen receptor beta expression in human prostate tissue. Molecular and Cellular Endocrinology, 178(1-2), 47-50.
141. Pedersen, S.B., Bruun, J.M., et al. (2001). Demonstration of estrogen receptor subtypes alpha and beta in human adipose tissue: influences of adipose cell differentiation and fat depot localization. Molecular and Cellular Endocrinology, 182(1), 27-37.
142. Perrot-Sinal, T. S., Davis, A. M., Gregerson, K. A., Kao, J. P., & McCarthy, M. M. (2001). Estradiol enhances excitatory gamma-aminobutyric [corrected] acid-mediated calcium signaling in neonatal hypothalamic neurons. Endocrinology, 142, 2238-2243.
143. Pierman, S., Sica, M., et al. (2008). Activational effects of estradiol and dihydrotestosterone on social recognition and the arginine-vasopressin immunoreactive system in male mice lacking a functional aromatase gene. Hormones and Behavior, 54(1), 98-106.
144. Price, T., Aitken, J., & Simpson, E. R. (1992). Relative expression of aromatase cytochrome P450 in human fetal tissues as determined by competitive polymerase chain reaction amplification. Journal of Clinical Endocrinology and Metabolism, 74, 879-883.
145. Price, T.M. & O'Brien, S.N. (1993). Determination of estrogen receptor messenger ribonucleic acid (mRNA) and cytochrome P450 aromatase mRNA levels in adipocytes and adipose stromal cells by competitive polymerase chain reaction amplification. Journal of Clinical Endocrinology and Metabolism, 77(4), 1041-1045.
146. Rasgon, N. L., Silverman, D., Siddarth, P., Miller, K., Ercoli, L. M., Elman, S., et al. (2005). Estrogen use and brain metabolic change in postmenopausal women. Neurobiology of Aging, 26, 229-235.
147. Raven, G., de Jong, F. H., Kaufman, J. M., & de Ronde, W. (2006). In men, peripheral estradiol levels directly reflect the action of estrogens at the hypothalamo-pituitary level to inhibit gonadotropin secretion. Journal of Clinical Endocrinology and Metabolism, 91, 3324-3328.
148. Robertson, K. M., O'Donnell, L., Jones, M. E., Meachem, S. J., Boon, W. C., Fisher, C. R., et al. (1999). Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene. Proceedings of the National Academy of Sciences of the United States of America, 96, 7986-7991.
149. Robertson, K. M., Simpson, E. R., Lacham-Kaplan, O., & Jones, M. E. (2001). Characterization of the fertility of male aromatase knockout mice. Journal of Andrology, 22, 825-830.
150. Rochira, V., Zirilli, L., Genazzani, A. D., Balestrieri, A., Aranda, C., Fabre, B., et al. (2006). Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: Evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback. European Journal of Endocrinology, 155, 513-522.
151. Roepke, T. A. (2009). Oestrogen modulates hypothalamic control of energy homeostasis through multiple mechanisms. Journal of Neuroendocrinology, 21, 141-150.
152. Romeo, R. D., McCarthy, J. B., Wang, A., Milner, T. A., & McEwen, B. S. (2005). Sex differences in hippocampal estradiol-induced N-methyl-D-aspartic acid binding and ultrastructural localization of estrogen receptor-alpha. Neuroendocrinology, 81, 391-399.
153. Roselli, C. E., Horton, L. E., & Resko, J. A. (1985). Distribution and regulation of aromatase activity in the rat hypothalamus and limbic system. Endocrinology, 117, 2471-2477.
154. Rozovsky, I.,Wei, M., Stone,D. J., Zanjani, H., Anderson, C. P., Morgan, T. E., et al. (2002). Estradiol (E2) enhances neurite outgrowth by repressing glial fibrillary acidic protein expression and reorganizing laminin. Endocrinology, 143, 636-646.
155. Rupprecht, R. & Holsboer, F. (1999). Neuroactive steroids: Mechanisms of action and neuropsychopharmacological perspectives. Trends in Neurosciences, 22, 410-416.
156. Sakamoto, H., Mezaki, Y., Shikimi, H., Ukena, K., & Tsutsui, K. (2003). Dendritic growth and spine formation in response to estrogen in the developing Purkinje cell. Endocrinology, 144, 4466-4477.
157. Sanchez, A. M., Flamini, M. I., Fu, X. D., Mannella, P., Giretti, M. S., Goglia, L., et al. (2009). Rapid signaling of estrogen to WAVE1 and moesin controls neuronal spine formation via the actin cytoskeleton. Molecular Endocrinology, 23, 1193-1202.
158. Sanchez, A. M. & Simoncini, T. (2009). Extra-nuclear signaling of ERalpha to the actin cytoskeleton in the central nervous system. Steroids. (in press).
159. Sanghera, M. K., Simpson, E. R., McPhaul, M. J., Kozlowski, G., Conley, A. J., & Lephart, E. D. (1991). Immunocytochemical distribution of aromatase cytochrome P450 in the rat brain using peptide-generated polyclonal antibodies. Endocrinology, 129, 2834-2844.
160. Santen, R. J., Brodie, H., Simpson, E. R., Siiteri, P. K., & Brodie, A. (2009). History of aromatase: Saga of an important biological mediator and therapeutic target. Endocrine Reviews, 30, 343-375.
161. 2+ channels. Proceedings of the National Academy of Sciences of the United States of America, 105, 15148-15153.
162. Sasahara, K., Shikimi, H., Haraguchi, S., Sakamoto, H., Honda, S., Harada, N., et al. (2007). Mode of action and functional significance of estrogen-inducing dendritic growth, spinogenesis, and synaptogenesis in the developing Purkinje cell. Journal of Neuroscience, 27, 7408-7417.
163. Sasano, H., Murakami, H., Shizawa, S., Satomi, S., Nagura, H., & Harada, N. (1999). Aromatase and sex steroid receptors in human vena cava. Endocrine Journal, 46, 233-242.
164. Sasano, H., Takashashi, K., Satoh, F., Nagura, H., & Harada, N. (1998). Aromatase in the human central nervous system. Clinical Endocrinology (Oxford), 48, 325-329.
165. Saunders, P.T., Millar, M.R., et al. (2000). Differential expression of estrogen receptor-alpha and -beta and androgen receptor in the ovaries of marmosets and humans. Biology of Reproduction, 63(4), 1098-1105.
166. Savolainen, H., Frosen, J., et al. (2001). Expression of the vasculoprotective estrogen receptor subtype beta in rat and human cardiac allograft vasculopathy. Transplantation Proceedings, 33(1-2), 1605.
167. Schwarz, J. M., Liang, S. L., Thompson, S. M., & McCarthy, M. M. (2008). Estradiol induces hypothalamic dendritic spines by enhancing glutamate release: A mechanism for organizational sex differences. Neuron, 58, 584-598.
168. Sebastian, S., Takayama, K., et al. (2002). Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue. Molecular Endocrinology, 16(10), 2243-2254.
169. Seralini, G. E., Tomilin, A., Auvray, P., Nativelle-Serpentini, C., Sourdaine, P., & Moslemi, S. (2003). Molecular characterization and expression of equine testicular cytochrome P450 aromatase. Biochimica et Biophysica Acta, 1625, 229-238.
170. Shapiro, E., Huang, H., et al. (2005a). Immunolocalization of estrogen receptor alpha and beta in human fetal prostate. The Journal of Urology, 174(5), 2051-2053.
171. Shapiro, E., Huang, H., et al. (2005b). Immunolocalization of androgen receptor and estrogen receptors alpha and beta in human fetal testis and epididymis. The Journal of Urology, 174(4 Pt 2), 1695-1698, discussion 1698.
172. Shim,G. J., Warner,M., Kim, H. J.,Andersson, S.,Liu,L.,Ekman, J., et al. (2004). Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome. Proceedings of the National Academy of Sciences of the United States of America, 101, 12628-12633.
173. Shozu, M., Zhao, Y., et al. (1998). Multiple splicing events involved in regulation of human aromatase expression by a novel promoter, I.6. Endocrinology, 139(4), 1610-1617.
174. Simpson, E. R. (2004). Aromatase: Biologic relevance of tissuespecific expression. Seminars in Reproductive Medicine, 22, 11-23.
175. Simpson, E. R., Mahendroo, M. S., Means, G. D., Kilgore, M. W., Corbin, C. J., & Mendelson, C. R. (1993). Tissuespecific promoters regulate aromatase cytochrome P450 expression. The Journal of Steroid Biochemistry and Molecular Biology, 44, 321-330.
176. Steimer, T. & Hutchison, J. B. (1981). Androgen increases formation of behaviourally effective oestrogen in dove brain. Nature, 292, 345-347.
177. Stockard, C. R. & Papanicolaou, G. N. (1917). A rhythmical "heat period" in the guinea-pig. Science, 46, 42-44.
178. Stoffel-Wagner, B., Watzka, M., Schramm, J., Bidlingmaier, F., & Klingmuller, D. (1999). Expression of CYP19 (aromatase) mRNA in different areas of the human brain. The Journal of Steroid Biochemistry and Molecular Biology, 70, 237-241.
179. Stoffel-Wagner, B., Watzka, M., Steckelbroeck, S., Schwaab, R., Schramm, J., Bidlingmaier, F., et al. (1998). Expression of CYP19 (aromatase) mRNA in the human temporal lobe. Biochemical and Biophysical Research Communications, 244, 768-771.
180. Takeda, K., Toda, K., et al. (2003). Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. Journal of Endocrinology, 176(2), 237-246.
181. Toda, K., Saibara, T., Okada, T., Onishi, S., & Shizuta, Y. (2001a). A loss of aggressive behaviour and its reinstatement by oestrogen in mice lacking the aromatase gene (Cyp19). Journal of Endocrinology, 168, 217-220.
182. Toda, K., Simpson, E. R., Mendelson, C. R., Shizuta, Y., & Kilgore, M. W. (1994). Expression of the gene encoding aromatase cytochrome P450 (CYP19) in fetal tissues. Molecular Endocrinology, 8, 210-217.
183. Toda, K., Takeda, K., Akira, S., Saibara, T., Okada, T., Onishi, S., et al. (2001b). Alternations in hepatic expression of fattyacid metabolizing enzymes in ArKO mice and their reversal by the treatment with 17beta-estradiol or a peroxisome proliferator. The Journal of Steroid Biochemistry and Molecular Biology, 79, 11-17.
184. Toda, K., Takeda, K., et al. (2001c). Alternations in hepatic expression of fatty-acid metabolizing enzymes in ArKO mice and their reversal by the treatment with 17beta-estradiol or a peroxisome proliferator. The Journal of Steroid Biochemistry and Molecular Biology, 79(1-5), 11-17.
185. Toda, K., Takeda, K. et al. (2001). Targeted disruption of the aromatase P450 gene (Cyp19) in mice and their ovarian and uterine responses to 17beta-oestradiol. J Endocrinol, 170 (1), 99-111.
186. Toth, B., Saadat, G., et al. (2008). Human umbilical vascular endothelial cells express estrogen receptor beta (ERbeta) and progesterone receptor a (PR-A), but not ERalpha and PR-B. Histochemistry and Cell Biology, 130(2), 399-405.
187. Valverde, M. A., Rojas, P., Amigo, J., Cosmelli, D., Orio, P., Bahamonde, M. I., et al. (1999). Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit. Science, 285, 1929-1931.
188. van Groen, T. & Kadish, I. (2005). Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology. Brain Research. Brain Research Reviews, 48, 370-378.
189. Vidal, O., Kindblom, L.G., et al. (1999). Expression and localization of estrogen receptor-beta in murine and human bone. Journal of Bone and Mineral Research, 14(6), 923-929.
190. Wang, L., Andersson, S., & Gustafsson, J. A. (2003). Estrogen receptor (ER)beta knockout mice reveal a role for ERbeta in migration of cortical neurons in the developing brain. Proceedings of the National Academy of Sciences of the United States of America, 100, 703-708.
191. Waters, E. M., Mitterling, K., Spencer, J. L., Mazid, S., McEwen, B. S., & Milner, T. A. (2009a). Estrogen receptor alpha and beta specific agonists regulate expression of synaptic proteins in rat hippocampus. Brain Research, 1290, 1-11.
192. Waters, E. M., Mitterling, K., Spencer, J. L., Mazid, S., McEwen, B. S., & Milner, T. A. (2009b). Estrogen receptor alpha and beta specific agonists regulate expression of synaptic proteins in rat hippocampus. Brain Research, 1290, 1-11.
193. Wetzel, C. H., Hermann, B., Behl, C., Pestel, E., Rammes, G., Zieglgansberger, W., et al. (1998). Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor. Molecular Endocrinology, 12, 1441-1451.
194. Wise, P. M., Dubal, D. B., Wilson, M. E., Rau, S. W., Bottner, M., & Rosewell, K. L. (2001). Estradiol is a protective factor in the adult and aging brain: Understanding of mechanisms derived from in vivo and in vitro studies. Brain Research. Brain Research Reviews, 37, 313-319.
195. Wesson, D.W., Keller, M., et al. (2006). Enhanced urinary odor discrimination in female aromatase knockout (ArKO) mice. Hormones and Behavior, 49(5), 580-586.
196. Woolley, C. S. & McEwen, B. S. (1992). Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. Journal of Neuroscience, 12, 2549-2554.
197. Xu, H., Gouras, G. K., Greenfield, J. P., Vincent, B., Naslund, J., Mazzarelli, L., et al. (1998). Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nature Medicine, 4, 447-451.
198. Xu, H., Wang, R., Zhang, Y. W., & Zhang, X. (2006). Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease. Annals of the New York Academy of Sciences, 1089, 324-342.
199. Yague, J. G., Munoz, A., Monasterio-Schrader, P., Defelipe, J., Garcia-Segura, L. M., & Azcoitia, I. (2006). Aromatase expression in the human temporal cortex. Neuroscience, 138, 389-401.
200. Yan, M., Jones, M. E., Hernandez, M., Liu, D., Simpson, E. R., & Chen, C. (2005). Oestrogen replacement in vivo rescues the dysfunction of pituitary somatotropes in ovariectomised aromatase knockout mice. Neuroendocrinology, 81, 158-166.
201. Youn, C. S., Kwon, O. S., Won, C. H., Hwang, E. J., Park, B. J., Eun, H. C., et al. (2003). Effect of pregnancy and menopause on facial wrinkling in women. Acta Dermato-Venereologica, 83, 419-424.
202. Yue, X., Lu, M., Lancaster, T., Cao, P., Honda, S., Staufenbiel, M., et al. (2005). Brain estrogen deficiency accelerates Aβ plaque formation in an Alzheimer's disease animal model. Proceedings of the National Academy of Sciences of the United States of America, 102, 19198-19203.
203. Znamensky, V., Akama, K. T., McEwen, B. S., & Milner, T. A. (2003). Estrogen levels regulate the subcellular distribution of phosphorylated Akt in hippocampal CA1 dendrites. Journal of Neuroscience, 23, 2340-2347.
204. Zhao, Y., Mendelson, C. R. et al. (1995). Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes. Molecular Endocrinology, 9(3), 340-349.